Tapentadol decreases the perception of soreness by blocking the transmission of soreness signals to the brain. A review with a direct-release formulation of tapentadol in subjects with hepatic impairment showed greater serum concentrations of tapentadol than in those with regular hepatic function. Avoid usage of NUCYNTA ER in sufferers with https://marionq159nzj0.wikipowell.com/user